Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010078027) CHLAMYDIA ANTIGENS AND USES THEREOF
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/078027 International Application No.: PCT/US2009/068457
Publication Date: 08.07.2010 International Filing Date: 17.12.2009
IPC:
A61K 39/118 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
118
Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
Applicants:
GENOCEA BIOSCIENCES, INC. [US/US]; 161 First Street Cambridge, MA 02139, US (AllExceptUS)
COHANE, Kenya [US/US]; US (UsOnly)
PICARD, Michele [US/US]; US (UsOnly)
GIERAHN, Todd [US/US]; US (UsOnly)
FLECHTNER, Jessica [US/US]; US (UsOnly)
Inventors:
COHANE, Kenya; US
PICARD, Michele; US
GIERAHN, Todd; US
FLECHTNER, Jessica; US
Agent:
FURMAN, Margo, H.; Choate, Hall & Stewart LLP Two International Place Boston, MA 02110, US
Priority Data:
61/138,26117.12.2008US
Title (EN) CHLAMYDIA ANTIGENS AND USES THEREOF
(FR) ANTIGÈNES DE CHLAMYDIAS ET LEURS UTILISATIONS
Abstract:
(EN) Disclosed are novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. Methods of using the antigens to elicit immune responses (e.g., T cellmediated and/or B cell-mediated immune responses) comprising administering an immunogenic composition including one or more of the novel antigens may be used for prophylaxis and/or treatment of chlamydia-mediated diseases.
(FR) La présente invention concerne de nouveaux antigènes de chlamydias, des acides nucléiques codant ces antigènes, et des compositions immunogènes contenant lesdits antigènes. La présente invention concerne en outre des procédés d'utilisation desdits antigènes pour déclencher des réponses immunitaires (par exemple, des réponses immunitaires à médiation lymphocytaire T et/ou à médiation lymphocytaire B) consistant à administrer une composition immunogène contenant un ou plusieurs nouveaux antigènes selon l'invention, qui peuvent être utilisés pour la prophylaxie et/ou le traitement de maladies médiées par des chlamydias.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2379106JP2012512257US20110293664CA2781805AU2009333159